Review Open Access
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2020; 8(15): 3164-3176
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3164
Progress of intravoxel incoherent motion diffusion-weighted imaging in liver diseases
Yun-Yun Tao, Yi Zhou, Ran Wang, Xue-Qin Gong, Jing Zheng, Cui Yang, Lin Yang, Xiao-Ming Zhang, Sichuan Key Laboratory of Medical Imaging, Department of Radiology and Medical Research Center of Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
ORCID number: Yun-Yun Tao (0000-0001-5081-331); Yi Zhou (0000-0002-1911-5380); Ran Wang (0000-0002-7013-4923); Xue-Qin Gong (0000-0001-8389-8765); Jing Zheng (0000-0002-2031-0845); Cui Yang (0000-0001-6751-9075); Lin Yang (0000-0001-8746-9255); Xiao-Ming Zhang (0000-0001-5327-8506).
Author contributions: Tao YY and Zhou Y are co-first authors; Tao YY and Zhou Y wrote the paper; Yang L revised the paper; Zhang XM designed the research; Wang R, Gong XQ, Zheng J and Yang C collected the data.
Supported by the Projects of the Department of Science and Technology of Sichuan Province, No. 2016JY0105.
Conflict-of-interest statement: The authors declare no conflict of interest with respect to this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Lin Yang, MD, Chief Doctor, Professor, Sichuan Key Laboratory of Medical Imaging, Department of Radiology and Medical Research Center of Affiliated Hospital of North Sichuan Medical College, No. 63 Wenhua Road, Nanchong 637000, Sichuan Province, China. linyangmd@163.com
Received: March 26, 2020
Peer-review started: March 26, 2020
First decision: May 29, 2020
Revised: June 11, 2020
Accepted: July 14, 2020
Article in press: July 14, 2020
Published online: August 6, 2020
Processing time: 133 Days and 3.2 Hours

Abstract

Traditional magnetic resonance (MR) diffusion-weighted imaging (DWI) uses a single exponential model to obtain the apparent diffusion coefficient to quantitatively reflect the diffusion motion of water molecules in living tissues, but it is affected by blood perfusion. Intravoxel incoherent motion (IVIM)-DWI utilizes a double-exponential model to obtain information on pure water molecule diffusion and microcirculatory perfusion-related diffusion, which compensates for the insufficiency of traditional DWI. In recent years, research on the application of IVIM-DWI in the diagnosis and treatment of hepatic diseases has gradually increased and has achieved considerable progress. This study mainly reviews the basic principles of IVIM-DWI and related research progress in the diagnosis and treatment of hepatic diseases.

Key Words: Magnetic resonance imaging; Diffusion magnetic resonance imaging; Liver diseases; Liver cirrhosis; Carcinoma; Cholangiocarcinoma

Core tip: Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) utilizes a double-exponential model to obtain information on pure water molecule diffusion and microcirculatory perfusion-related diffusion, which makes up for the insufficiency of traditional DWI. In recent years, research on the application of IVIM-DWI in the diagnosis and treatment of hepatic diseases has gradually increased and has made great progress. This study mainly reviews the basic principles of IVIM-DWI and its research progress in the diagnosis and treatment of hepatic diseases.



INTRODUCTION

Magnetic resonance diffusion-weighted imaging (MR-DWI) uses a single exponential model to obtain the apparent diffusion coefficient (ADC) to quantitatively reflect the diffusion motion of water molecules in tissues[1]. However, voxels also contain diffusion information other than the diffusion motion of pure water molecules, namely, the microcirculatory perfusion of the capillary network in tissues[1-4]. The ADC values obtained by traditional DWI contain two types of information: Water molecule diffusion and microcirculatory perfusion. The intravoxel incoherent motion (IVIM)-DWI theory was initially proposed by Le Bihan et al[4,5] in the 1980s; IVIM-DWI can obtain quantitative information on pure water molecule diffusion and micro-circulatory perfusion-related diffusion and thus compensate for the shortcomings of traditional DWI. This modality can also more accurately and truly reflect the characteristics of tissue structure and pathological changes. Since 1999, when Yamada et al[6] for the first time applied IVIM-DWI technology to the liver, the research on liver IVIM-DWI has gradually increased and has made great progress. This study reviews the basic principles of IVIM-DWI and related research progress in the diagnosis and treatment of hepatic diseases.

BASIC PRINCIPLES OF IVIM-DWI

IVIM-DWI originated from diffusion-weighted magnetic resonance imaging (MRI). MR-DWI can noninvasively detect the diffusion motion of water molecules (water molecules in fluid exhibit microscopic erratic random movement, known as Brownian motion), which reflects the biological characteristics of the tissue. When the signal derives from biological tissues, some factors attenuate the diffusion motion according to different diffusion coefficients, representing the ADC, which is the sum of the contributions of all motion-related diffusion coefficients. The MR signal can be expressed by a single exponential equation:

Sb/S0 = exp(-b×ADC).

Where b is the diffusion-sensitive gradient with a unit of s/mm2; Sb represents the signal obtained at a particular b value; and S0 represents a signal that does not apply a diffusion gradient[7].

IVIM-DWI uses multiple b values and a double-exponential model for image acquisition and analysis, and simultaneously obtains information regarding pure water molecular diffusion and microcirculatory perfusion-related diffusion. IVIM-DWI measures perfusion based on the following assumption: The effects of incoherent motion and blood movement can be separated from other incoherent effects. The IVIM-DWI model assumes that other sources of incoherent signals (water exchange between blood and tissue) are negligible compared with blood flow. In the IVIM-DWI model, the relationship between the degree of local signal attenuation in the tissue and the b value can be expressed by the following formula[8]:

Sb/S0= (1-f) ×exp(-b×D) +f×exp(-b×D*).

Where D is the simple diffusion coefficient, also known as slow the apparent diffusion coefficient (Dslow), which reflects the diffusion motion of pure water molecules in the tissue of interest; D* is the pseudo-diffusion coefficient, also known as the fast apparent diffusion coefficient (Dfast), which reflects the microcirculatory perfusion in the capillary network in the area of interest; and f is the fraction of the fast apparent diffusion coefficient, which represents the volume ratio of the correlation effect of the local microcirculatory perfusion to the total diffusion effect and can be used to determine the blood volume in the area of interest. According to the formula, since D* is obviously higher than D, the information obtained from a low b value (< 200 s/mm2) mainly reflects the microcirculatory perfusion effect, while the signal attenuation obtained by a high b value (≥ 200 s/mm2) mainly reflects the diffusion effect[5,9]. Some researchers[10] believe that f × D* should be used as a new cyclic parameter and that its potential pathophysiological effects should be further elaborated in future studies.

Multiple b values are required for IVIM-DWI to separate tissue diffusion information from perfusion information. Theoretically, more b values correspond to a more accurate data fit and thus better image quality. However, a longerdata collection time corresponds to more clinical application limitations. The number of b values used in published studies ranges from 4 to16, with many studies using approximately 10 b values[6,9,11,12]. In terms of the distribution of b values, Cohen et al[13] studied the influence of low b values on D* and showed that at least two b values below 50 s/mm2 are required to ensure that D* is not underestimated. Koh et al[14] proposed selecting fewer high b values and more low b values to focus data collection on the sensitive range of perfusion. At present, no consensus on the choice of b values is available, and optimization research on the number and distribution of b values is ongoing[11,15-17]. For clinical research, the choice of b values should be based on the different tissues tested and the purpose of the evaluation. The factors influencing the measurement results of IVIM-DWI are complex. In addition to b values, scanner and field intensities[11], the diffusion gradient and respiratory mode[18,19], the DWI sequence[20,21], other physiological activities (such as glandular secretions and fluid flow in glandular canals)[22], motion artefacts, fitting technology and region of interest (ROI) settings[23-28] can all affect the IVIM-DWI image quality and repeatability of the data. These should also be considered in the clinical study design.

NONALCOHOLIC FATTY LIVER DISEASE

In recent years, the prevalence of fatty liver disease in China has gradually increased, and the onset of the disease is trending to involve youngerpatients. Approximately 20% of noninvasive nonalcoholic fatty liver disease (NAFLD) casesdevelop into nonalcoholic steatohepatitis, which can progress to hepatic fibrosis or even cirrhosis[29]. Studies have shown that[30-33] the histological characteristics of nonalcoholic hepatic steatosis significantly affect the IVIM-DWI parameters. Parente et al[31] used IVIM-DWI to study type II diabetic patients with or without NAFLD and found that both the D value and D* value of fatty livers were significantly lower than those of non-fatty livers. The decrease in the D* value reflects the decrease in hepatic perfusion caused by hepatic steatosis, whereas the decrease in the D value may be caused by hepatocytomegaly, the deposition of intracellular fat and the simultaneous restriction of water molecule diffusion intracellularly and extracellularly[33]. The study by Joo et al[34] showed that the f value of NAFLD livers was significantly lower than that of normal livers, and this f value is associated with the severity of NAFLD.

HEPATIC FIBROSIS

Although percutaneous liver biopsy can determine the severity of hepatic fibrosis, this test is invasive, and its clinical application is limited. IVIM-DWI has important value in the evaluation of hepatic fibrosis[9,12,19,35-47].

Studies[12,44,45] have shown that the D, D* and f values of hepatic fibrosis patients were significantly lower than those in normal control groups. The IVIM-DWI parameters D, D* and f can be used to distinguish healthy people from patients with hepatic fibrosis, with the f value exhibiting the best diagnostic value[38].The study by Shiraga et al[36] showed that IVIM-DWI also identified a pre-fibrotic state of the liver in Fontan patients. The study included five consecutive Fontan patients and four age-matched healthy volunteers. The results showed that in the five Fontan patients, laboratory tests and ultrasound showed almost normal liver conditions, and cardiac catheterization and MRI showed good Fontan circulation, but the D, D* and f values of Fontan patients were significantly lower than those of the control group. However, some studies[9,41,46] have shown that the D value was not significantly different between normal liver tissue and hepatic fibrosis tissue. Dyvorne et al[19] showed that D* values were not significantly different between normal volunteers and patients with hepatic fibrosis.

In addition, many studies have focused on the use of IVIM-DWI technology to determine the severity of hepatic fibrosis, but the conclusions are not completely consistent[12,37-45,47]. Hu et al[40,45] showed that IVIM-DWI-related parameters were negatively correlated with hepatic fibrosis stages, with the D, D* and f value decreasing with increases in the severity of hepatic fibrosis. Chen et al[45] used IVIM-DWI to scan 25 patients with hepatic fibrosis and 25 healthy volunteers. The results showed that the ADC, D, D* and f values in the hepatic cirrhosis group were significantly lower than those in the control group. Additionally, significant differences were found in the parameters of hepatic fibrosis stages (the F0-1 group and F2-4 group and theF0-2 group and F3-4 group). However, further studies have shown that some parameters are not correlated with the hepatic fibrosis stage[37-39,41-44]. For example, Chung et al[41-44] showed that a higher stage of hepatic fibrosis corresponded to lower D* and f values; however, no correlation was found between the D values and the stages of hepatic fibrosis. On the other hand, Hu et al[39] observed a difference only in the D* values in different fibrosis groups. Other studies[48-51] have shown that IVIM-DWI is not sufficient for staging hepatic fibrosis (Table 1). The different D and D* values in the same disease of the previous studies maybe due to the following reasons: (1) The number of patients with each stage of disease was different; (2) The number of b values or an uneven b value distribution may limit the fitting precision; (3) D* has high uncertainty and poor reproducibility; and (4) D values were influenced by steatosis and iron overload[19,45,50].

Table 1 Summary of hepatic fibrosis intravoxel incoherent motion diffusion-weighted imaging studies.
Ref.Subject numberKey findings
Chen et al[45]50The ADC, Dslow, Dfast, and FF values of liver fibrosis stages between the groups F0-1 and F2-4, and the groups F0-2 and F3-4 showed significant differences. As the stage of fibrosis increased, the values decreased
Hu et al[40]57Significant differences in D, f, D* and ADC values were found between stages (stages F0–F4). Inverse correlations were identified between fibrosis stages and D, f, D*, and ADC values
Ichikawa et al[41]129D*, f and ADC values decreased with fibrosis stage
Wu et al[43]49Liver fibrosis exhibited significant correlations with Dfast and fvalues. Dfast values in the F4 group were significantly lower than those in the F0, F1 and F2 groups
Hu et al[39]56The mean, interquartile (IQ) range, and percentiles (50th, 75th and 90th) of D* maps were significantly different between the F0–1, F2–3 and F4 groups
Huang et al[48]42IVIM diffusion MRI has high diagnostic performance in detecting viral hepatitis B-induced liver fibrosis
Liang et al[49]30The D value decreased as the fibrosis level increased
Franca et al[50]74ADC and f values were lower with higher fibrosis stages

In summary, the IVIM-DWI parameters of hepatic fibrosis tissues show a decreasing trend compared with those of normal hepatic tissues, and IVIM-DWI can be used for the diagnosis of hepatic fibrosis; however, the value of applying IVIM-DWI for hepatic fibrosis staging still requires further exploration.

DIFFERENTIATION OF BENIGN AND MALIGNANT HEPATIC TUMORS

A large number of studies have discussed the application of IVIM-DWI in the diagnosis of hepatic tumors. Studies have shown that[6,52-58] IVIM-DWI can be used for the diagnosis and differentiation of benign and malignant hepatic tumours, and a consensus indicates that the ADC and D values have high efficacy for differential diagnosis. The D value is the only simple diffusion coefficient sensitive to water molecule diffusion. For malignant lesions characterized by diffusion restriction, the D value has higher diagnostic efficiency than the ADC[54-56]. Lou et al[54] performed IVIM-DWI on 74 patients with hepatic tumors and showed that the ADC, D and f values in the malignant group were significantly lower than those in the benign group, with a larger area under the curve for the D value (0.968) and higher differentiation sensitivity (92.30%); however, no statistically significant difference in the D* value was foundbetween the two groups. Furthermore, conflicting results have been reported[53,57,59]. The results of the study by Watanabe et al[57] showed that for the identification of benign and malignant hepatic tumors, the area under the receiver operating characteristic (ROC) curve of the ADC value was higher than that of the D value; and Doblas et al[59] suggested that compared with the ADC value, IVIM-DWI parameters could not improve the differentiation efficiency for hepatic focal lesions.

The use of the perfusion-related parameters D* and f for the differentiation of benign and malignant nodules is controversial[58,60]. Penner AH et al[60]showed that compared with the traditional ADC, IVIM-DWI parameters were more significantly different between lesions and normal liver tissue. Ichikawa et al[58] studied 84 cases of focal benign and malignant hepatic lesions and found that the D and D* values of malignant hepatic lesions were significantly lower than those of benign hepatic lesions, while the f values showed no difference between benign and malignant hepatic lesions. These results suggested that the D* and D values were inhibited in malignant lesions. In contrast, some studies[52-54,61] have suggested that the D* and f values are meaningless for differentiating benign and malignant hepatic lesions. A possible reason is that the D* value may fluctuate in a large range due to different blood supply types in hepatic hemangiomas[52,61], while the magnitude of the f value depends on the time of echo (TE) (a longer TE corresponds to a greater f value). In addition, D* and f values are not uniquely specific to perfusion and may also be sensitive to other flow information, such as the excretion, direction or pattern of diffusion of a granule or gland[53,57,62] (Figures 1 and 2, Table 2).

Figure 1
Figure 1 A 51-year-old male patient with hepatocellular carcinoma in the right lobe of the liver. The tumor was hypointense on T1-weighted image (T1WI) and hyperintense on T2-weighted image (T2WI). Theapparent diffusion coefficient (ADC), D, D*and f maps were obtained by post processing of IVIM-DWI images. A: T1WI; B: T2WI; C: ADC map; D: D map; E: D* map; F: F map.
Table 2 Summary of hepatic nodules intravoxel incoherent motion diffusion-weighted imaging studies.
Ref.Subject numberKey findings
Luo et al[53]27ADCtotal, D, and D* values of HCC were lower than those of focal nodular hyperplasia
Luo et al[54]75ADCtotal, D, and f values of malignant lesions were lower than those of benign lesions
Klauss et al[55]72D and ADC values of HCC were lower than those of focal nodular hyperplasia
Yoon et al[56]157True diffusion and ADCtotal of malignancies were lower than those of benign malignant lesions
Watanabe et al[57]120D and ADC values were lower in the malignant group than in the benign group
Ichikawa et al[58]84D and D* values of malignant lesions were lower than those of benign lesions
Doblas et al[59]86The apparent and pure diffusion coefficients were lower in malignant than in benign tumors
Penner et al[60]61ROC analysis demonstrated the best discriminability between HCCs and focal nodular hyperplasia for ADCslow and f values
Zhu et al[61]39ADCtotal and D values of malignancies were lower than those of hemangioma
Figure 2
Figure 2 A 28-year-old female patient with focal nodular hyperplasia in the left lobe of the liver. The tumor was isointense on T1-weighted image (T1WI) and T2-weighted image (T2WI) with a star-shaped area in the center of the lesion (hypointense on T1WI and hyperintense on T2WI). A: T1WI; B: T2WI; C: ADC map; D: D map; E: D* map; F: F map.
DIFFERENTIATION OF HEPATIC MALIGNANCIES WITH DIFFERENT PATHOLOGICAL TYPES

Few studies have investigated IVIM-DWI for the differentiation of hepatic malignancies of different pathological types. Previous studies have suggested that IVIM-DWI is beneficial for the differentiation of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC)[63-66], but the differentiation of HCC and metastatic hepatic cancer requires further study[52]. Shao et al[64] discussed the role of IVIM-DWI in differentiating hepatitis B virus (HBV)-related ICC from HCC and found that the ADC and D values of ICC were significantly higher than those of HCC, while the f value of ICC was significantly lower than that of HCC, and the areas under the ROC curves of the ADC, D and f values were 0.724, 0.753 and 0.741, respectively. Wei et al[63] showed that the ADC and D value could differentiate ICC from HCC. However, the D* and f values showed no difference in the ICC and HCC groups. Choi et al[65]studied 161 cases of focal hepatic lesions using IVIM-DWI. The results showed no significant difference in the ADC value in any malignant tumor. The Dslow value of HCC was significantly lower than that of ICC, and the f value was significantly higher than those of ICC and metastatic carcinoma. A meta-analysis conducted by Wu et al[52] (six papers meeting the requirements) showed that the ADC, D, D* and f values were not significantly different between metastatic liver cancer and HCC. The reason for this finding may be that these metastases originated from some primary tumors such as lesions in the gastrointestinal tract, lung, breast or urogenital system, which may have caused some changes in cell density and microcirculation. In addition, different HCC histological classifications and compositions used in different studies may have also caused certain effects.

HCC HISTOLOGICAL CLASSIFICATION

Studies have shown that the IVIM-DWI parameters of HCC are correlated with histological classification[19,67-75]. Li et al[73] performed an IVIM-DWI analysis on a rat model of hepatic cancer and showed that the ADC and D values of higher-grade lesions were lower than those of lower-grade lesions, and the ADC and D values were negatively correlated with the tumor’s histological classification. The D* and f values of higher-grade lesions were higher than those of lower-grade lesions, and the D* and f values were positively correlated with the tumor histological classification. During tumorigenesis, as the degree of tumor differentiation becomes increasingly poor, the cellularity and nuclear-to-cytoplasmic ratio increase, and as the extracellular space decreases, water diffusion is restricted, resulting in reduced ADC and D values in poorly differentiated HCC[68,69].

Regarding the role of D* and f values in the histological classification of HCC, the results of available studies are not completely consistent. Sokmen et al[71] showed that the ADC and D values were negatively correlated with the histological classification of HCC, the f value was positively correlated with the histological classification of HCC tissue, and no differences in the D* value in different histological classifications of HCC were observed. Granata et al[74,75] observed the role of the ADC, D and f values in differentiating the histological classifications of HCC but did not observe any significance of the D* value for differentiation. Other studies showed only the roles of the ADC and D value in the differentiation of the histological classifications of HCC, and the roles of D* and f values in differentiation were not observed[19,67-69], which may be explained by differences in b-value groupings and patient populations as well as consequent variation in tumor grade distributions[67,75].

EVALUATION OF THE HCC TREATMENT RESPONSE

Studies have shown that IVIM-DWI has important application value in the treatment and follow-up of HCC.

Zhang et al[76] conducted IVIM-DWI on 157 patients with HBV-related HCC who underwent surgical resection. The results showed 47 cases of tumor recurrence, and a D value < 0.985 × 10-3 mm2/s was found to be a risk factor for recurrence. The D value of the IVIM-DWI model has been suggested as a potential biomarker for preoperative prediction of hepatic cancer recurrence[77-79]. Zhao et al[78] reported that D is an independent predictor of microvascular invasion (MVI); when the cut-off D value was 1.16 × 10-3 mm2/s, the sensitivity and specificity for predicting MVI were 66.7% and 88.9, respectively.

IVIM-DWI parameters can distinguish the survival area, the fibrous area and the necrotic area of malignant hepatic tumors[80]. A study[81] including 15 patients undergoing resection of hepatic metastases of colorectal cancer found that the ADC and D values were associated with the degree of necrosis of metastatic hepatic tumors, suggesting that the specificity of free molecular proliferation of metastatic colorectal cancer increased after systemic chemotherapy.

In the early stages of local or targeted therapy for tumors, changes in tumor volume are often not detected by traditional imaging, and functional imaging is of great value in this field[82,83]. IVIM-DWI parameters can be used as biomarkers for early response evaluation[84-88]. Studies have shown that IVIM-DWI has important value in the evaluation of transarterial chemoembolization (TACE) treatment responses and the prediction of therapeutic effects in HCC[84,89-93]. The study by Peng et al[91] showed that after TACE treatment for HCC, the ADC and D values in tumor tissues significantly increased, the D* value decreased significantly, and the f value did not change significantly. The reason for the inconsistent changes in these two perfusion-related parameters may be that the D* and f values represent different aspects of perfusion, the former is mainly related to the capillary velocity of local tissues, while the latter is related to the blood volume of local tissues. The study by Park et al[89] showed that the D* value could reflect the blood supply of HCC and predict the deposition effect of iodide oil after TACE surgery; the D* value and arterial enhancement ratio (AER) of preoperative lesions in the group with better iodized oil deposition were significantly higher than those in the group with poor iodized oil deposition. Wu et al[92] believed that the ADC maybe the best independent predictor of TACE treatment responses.

The IVIM-DWI perfusion parameter f is significantly correlated with microvascular dysplasia (MVD) in HCC[88]. IVIM-DWI can be used to evaluate the anti-angiogenic effect of sorafenib on HCC[87,88,94-96]. Yang et al[95] established 35 nude mouse models of HCC and conducted IVIM-DWI at baseline and 7, 14 and 21 dafter sorafenib treatment. The results revealed that compared with the control group, the ADC and D values in the treatment group at each time point were significantly increased, while the f value was significantly decreased at 7 d and significantly increased at 21 d. In the treatment group, both the ADC and D values were significantly higher than the baseline values on days 7, 14 and 21, while the f value decreased significantly on the 7th day and increased significantly on the 21st day. In the treatment group, the ADC, D and f values were significantly correlated with the necrotic fraction (NF). These results suggested that IVIM-DWI parameters can be used as biomarkers to evaluate the therapeutic efficacy of sorafenib therapy for HCC. Shirota et al[87] conducted IVIM-DWI on nine patients with HCC treated with sorafenib, and the results showed that the baseline D value in the responsive group was significantly higher than that in the non-responsive group. The sensitivity and specificity of the differential therapeutic responses were 100% and 67%, respectively, and the other parameters showed no difference between the two groups, suggesting that the D value can be used to predict the therapeutic response of HCC to sorafenib.

OTHER DISEASES

The application of IVIM-DWI in hepatic ischemia-reperfusion injury (IRI)[97-99], hepatic alveolar echinococcosis[100], hepatic dysfunction[101], hepatic sinus obstruction syndrome[102] and other diseases is also gradually developing. For example, studies have found that IVIM-DWI-related parameters are significantly reduced after liver IRI[99].

CONCLUSION

In conclusion, IVIM-DWI seems to accurately reflect information related to the diffusion of simple water molecules and microcirculatory perfusion in tissues and it could have important application value in the diagnosis of hepatic fibrosis, the differentiation of benign and malignant hepatic lesions, the histological classification of HCC, the evaluation of local and targeted therapeutic response and the prediction of therapeutic efficacy. However, the value of IVIM-DWI in assisting in the histological classification of hepatic fibrosis and in differentiating malignant hepatic tumors with different pathological characteristics still requires further investigation. The standardization of IVIM-DWI scanning technology (such as the optimization and standardization of the number and distribution of b values) is an important topic, which warrants further study. In addition, the characteristics and diagnostic value of the D* and f values still require further exploration. With continuous innovation in IVIM-DWI technology and in-depth clinical research, IVIM-DWI will play a more important role in the diagnosis and treatment of hepatic diseases in the future.

Footnotes

Manuscript source: Unsolicited manuscript

Specialty type: Medicine, research and experimental

Country/Territory of origin: China

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C

Grade D (Fair): D

Grade E (Poor): 0

P-Reviewer: Fiore M, Zhou M S-Editor: Gong ZM L-Editor: Webster JR E-Editor: Liu JH

References
1.  Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47-66.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 623]  [Cited by in F6Publishing: 597]  [Article Influence: 42.6]  [Reference Citation Analysis (2)]
2.  Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol. 2003;45:169-184.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 562]  [Cited by in F6Publishing: 515]  [Article Influence: 24.5]  [Reference Citation Analysis (0)]
3.  Lewis S, Dyvorne H, Cui Y, Taouli B. Diffusion-weighted imaging of the liver: techniques and applications. MagnReson Imaging Clin N Am. 2014;22:373-395.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 40]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
4.  Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497-505.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2349]  [Cited by in F6Publishing: 2386]  [Article Influence: 66.3]  [Reference Citation Analysis (0)]
5.  Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2776]  [Cited by in F6Publishing: 2585]  [Article Influence: 68.0]  [Reference Citation Analysis (0)]
6.  Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology. 1999;210:617-623.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 412]  [Cited by in F6Publishing: 409]  [Article Influence: 16.4]  [Reference Citation Analysis (0)]
7.  Federau C. Intravoxel incoherent motion MRI as a means to measure in vivo perfusion: A review of the evidence. NMR Biomed. 2017;30.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 63]  [Cited by in F6Publishing: 72]  [Article Influence: 10.3]  [Reference Citation Analysis (0)]
8.  Paschoal AM, Leoni RF, Dos Santos AC, Paiva FF. Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases. Neuroimage Clin. 2018;20:705-714.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 48]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
9.  Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L, Laurent A, Deux JF, Brugieres P, Rahmouni A. Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology. 2008;249:891-899.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 495]  [Cited by in F6Publishing: 514]  [Article Influence: 32.1]  [Reference Citation Analysis (0)]
10.  Bisdas S, Braun C, Skardelly M, Schittenhelm J, Teo TH, Thng CH, Klose U, Koh TS. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? NMR Biomed. 2014;27:1184-1191.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 44]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
11.  Dyvorne H, Jajamovich G, Kakite S, Kuehn B, Taouli B. Intravoxel incoherent motion diffusion imaging of the liver: optimal b-value subsampling and impact on parameter precision and reproducibility. Eur J Radiol. 2014;83:2109-2113.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 66]  [Article Influence: 6.6]  [Reference Citation Analysis (0)]
12.  Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J MagnReson Imaging. 2010;31:589-600.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 299]  [Cited by in F6Publishing: 304]  [Article Influence: 21.7]  [Reference Citation Analysis (0)]
13.  Cohen AD, Schieke MC, Hohenwalter MD, Schmainda KM. The effect of low b-values on the intravoxel incoherent motion derived pseudodiffusion parameter in liver. MagnReson Med. 2015;73:306-311.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 80]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
14.  Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol. 2011;196:1351-1361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 410]  [Cited by in F6Publishing: 418]  [Article Influence: 32.2]  [Reference Citation Analysis (0)]
15.  Jalnefjord O, Montelius M, Starck G, Ljungberg M. Optimization of b-value schemes for estimation of the diffusion coefficient and the perfusion fraction with segmented intravoxel incoherent motion model fitting. MagnReson Med. 2019;82:1541-1552.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 31]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
16.  Mürtz P, Sprinkart AM, Reick M, Pieper CC, Schievelkamp AH, König R, Schild HH, Willinek WA, Kukuk GM. Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI. EurRadiol. 2018;28:4418-4428.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
17.  Meeus EM, Novak J, Dehghani H, Peet AC. Rapid measurement of intravoxel incoherent motion (IVIM) derived perfusion fraction for clinical magnetic resonance imaging. MAGMA. 2018;31:269-283.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 17]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
18.  Wong OL, Goh Lo G, Yuan J, Chung WK, Ho WHB, Noseworthy MD. Evaluation and Minimization of the Pseudohepatic Anisotropy Artifact in Liver Intravoxel Incoherent Motion. J Comput Assist Tomogr. 2017;41:679-687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
19.  Dyvorne HA, Galea N, Nevers T, Fiel MI, Carpenter D, Wong E, Orton M, de Oliveira A, Feiweier T, Vachon ML, Babb JS, Taouli B. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters--a pilot study. Radiology. 2013;266:920-929.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 144]  [Cited by in F6Publishing: 149]  [Article Influence: 12.4]  [Reference Citation Analysis (0)]
20.  Xiang Z, Ai Z, Liang J, Li G, Zhu X, Yan X. Evaluation of Regional Variability and Measurement Reproducibility of Intravoxel Incoherent Motion Diffusion Weighted Imaging Using a Cardiac Stationary Phase Based ECG Trigger Method. Biomed Res Int. 2018;2018:4604218.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
21.  Li J, Zhang C, Cui Y, Liu H, Chen W, Wang G, Wang D. Intravoxel incoherent motion diffusion-weighted MR imaging of the liver using respiratory-cardiac double triggering. Oncotarget. 2017;8:94959-94968.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
22.  Neil JJ, Bretthorst GL. On the use of Bayesian probability theory for analysis of exponential decay data: an example taken from intravoxel incoherent motion experiments. MagnReson Med. 1993;29:642-647.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 101]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
23.  Ahn SJ, Shin HJ, Chang JH, Lee SK. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods. PLoS One. 2014;9:e112948.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 53]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
24.  Blazic IM, Lilic GB, Gajic MM. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging. Radiology. 2017;282:418-428.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 60]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
25.  Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RK, Bibeau F, Azria D, Assenat E, Molinari N, Pierredon MA, Rouanet P, Guiu B. Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. Radiology. 2016;280:446-454.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 117]  [Cited by in F6Publishing: 141]  [Article Influence: 17.6]  [Reference Citation Analysis (0)]
26.  Giordano M, Samii A, Samii M, Nabavi A. Magnetic Resonance Imaging-Apparent Diffusion Coefficient Assessment of Vestibular Schwannomas: Systematic Approach, Methodology, and Pitfalls. World Neurosurg. 2019;125:e820-e823.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 4]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
27.  Wang S, Meng M, Zhang X, Wu C, Wang R, Wu J, Sami MU, Xu K. Texture analysis of diffusion weighted imaging for the evaluation of glioma heterogeneity based on different regions of interest. Oncol Lett. 2018;15:7297-7304.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 11]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
28.  Ahlawat S, Khandheria P, Del Grande F, Morelli J, Subhawong TK, Demehri S, Fayad LM. Interobserver variability of selective region-of-interest measurement protocols for quantitative diffusion weighted imaging in soft tissue masses: Comparison with whole tumor volume measurements. J MagnReson Imaging. 2016;43:446-454.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 47]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
29.  Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-2023.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2413]  [Cited by in F6Publishing: 2528]  [Article Influence: 210.7]  [Reference Citation Analysis (1)]
30.  Murphy P, Hooker J, Ang B, Wolfson T, Gamst A, Bydder M, Middleton M, Peterson M, Behling C, Loomba R, Sirlin C. Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. J MagnReson Imaging. 2015;41:1629-1638.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 48]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
31.  Parente DB, Paiva FF, Oliveira Neto JA, Machado-Silva L, Figueiredo FA, Lanzoni V, Campos CF, do Brasil PE, Gomes Mde B, Perez Rde M, Rodrigues RS. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients. PLoS One. 2015;10:e0125653.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 33]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
32.  Shin HJ, Yoon H, Kim MJ, Han SJ, Koh H, Kim S, Lee MJ. Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children. World J Gastroenterol. 2018;24:3013-3020.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 15]  [Cited by in F6Publishing: 21]  [Article Influence: 3.5]  [Reference Citation Analysis (1)]
33.  Guiu B, Petit JM, Capitan V, Aho S, Masson D, Lefevre PH, Favelier S, Loffroy R, Vergès B, Hillon P, Krausé D, Cercueil JP. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology. 2012;265:96-103.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 123]  [Cited by in F6Publishing: 129]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
34.  Joo I, Lee JM, Yoon JH, Jang JJ, Han JK, Choi BI. Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model. Radiology. 2014;270:131-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 52]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
35.  Yoon JH, Lee JM, Lee KB, Kim D, Kabasawa H, Han JK. Comparison of monoexponential, intravoxel incoherent motion diffusion-weighted imaging and diffusion kurtosis imaging for assessment of hepatic fibrosis. ActaRadiol. 2019;60:1593-1601.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 11]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
36.  Shiraga K, Ono K, Inuzuka R, Asakai H, Ookubo T, Shirayama A, Higashi K, Nakajima H. Intravoxel incoherent motion imaging has the possibility to detect liver abnormalities in young Fontan patients with good hemodynamics. Cardiol Young. 2019;29:898-903.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
37.  Tosun M, Onal T, Uslu H, Alparslan B, ÇetinAkhan S. Intravoxel incoherent motion imaging for diagnosing and staging the liver fibrosis and inflammation. AbdomRadiol (NY). 2020;45:15-23.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 22]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
38.  Wáng YXJ, Deng M, Li YT, Huang H, Leung JCS, Chen W, Lu PX. A Combined Use of Intravoxel Incoherent Motion MRI Parameters Can Differentiate Early-Stage Hepatitis-b Fibrotic Livers from Healthy Livers. SLAS Technol. 2018;23:259-268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 24]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
39.  Hu F, Yang R, Huang Z, Wang M, Zhang H, Yan X, Song B. Liver fibrosis: in vivo evaluation using intravoxel incoherent motion-derived histogram metrics with histopathologic findings at 3.0 T. AbdomRadiol (NY). 2017;42:2855-2863.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 11]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
40.  Hu G, Chan Q, Quan X, Zhang X, Li Y, Zhong X, Lin X. Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. J MagnReson Imaging. 2015;42:331-339.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 25]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
41.  Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J MagnReson Imaging. 2015;42:204-210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 58]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
42.  Chung SR, Lee SS, Kim N, Yu ES, Kim E, Kühn B, Kim IS. Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. ActaRadiol. 2015;56:1428-1436.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 44]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
43.  Wu CH, Ho MC, Jeng YM, Liang PC, Hu RH, Lai HS, Shih TT. Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. EurRadiol. 2015;25:3552-3559.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 27]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
44.  Lu PX, Huang H, Yuan J, Zhao F, Chen ZY, Zhang Q, Ahuja AT, Zhou BP, Wáng YX. Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. PLoS One. 2014;9:e113846.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 38]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
45.  Chen C, Wang B, Shi D, Fu F, Zhang J, Wen Z, Zhu S, Xu J, Lin Q, Li J, Dou S. Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis. Chin Med J (Engl). 2014;127:3082-3087.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Zhang Y, Jin N, Deng J, Guo Y, White SB, Yang GY, Omary RA, Larson AC. Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. MagnReson Imaging. 2013;31:1017-1021.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 26]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
47.  Hayashi T, Miyati T, Takahashi J, Fukuzawa K, Sakai H, Tano M, Saitoh S. Diffusion analysis with triexponential function in liver cirrhosis. J MagnReson Imaging. 2013;38:148-153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 41]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
48.  Huang H, Che-Nordin N, Wang LF, Xiao BH, Chevallier O, Yun YX, Guo SW, Wáng YXJ. High performance of intravoxel incoherent motion diffusion MRI in detecting viral hepatitis-b induced liver fibrosis. Ann Transl Med. 2019;7:39.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 21]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
49.  Liang J, Song X, Xiao Z, Chen H, Shi C, Luo L. Using IVIM-MRI and R2⁎ Mapping to Differentiate Early Stage Liver Fibrosis in a Rat Model of Radiation-Induced Liver Fibrosis. Biomed Res Int. 2018;2018:4673814.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 13]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
50.  França M, Martí-Bonmatí L, Alberich-Bayarri Á, Oliveira P, Guimaraes S, Oliveira J, Amorim J, Gonzalez JS, Vizcaíno JR, Miranda HP. Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging. AbdomRadiol (NY). 2017;42:468-477.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 43]  [Article Influence: 6.1]  [Reference Citation Analysis (0)]
51.  Yoon JH, Lee JM, Baek JH, Shin CI, Kiefer B, Han JK, Choi BI. Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr. 2014;38:110-116.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 73]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
52.  Wu H, Liang Y, Jiang X, Wei X, Liu Y, Liu W, Guo Y, Tang W. Meta-analysis of intravoxel incoherent motion magnetic resonance imaging in differentiating focal lesions of the liver. Medicine (Baltimore). 2018;97:e12071.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 17]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
53.  Luo M, Zhang L, Jiang XH, Zhang WD. Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia. DiagnIntervRadiol. 2017;23:263-271.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
54.  Luo M, Zhang L, Jiang XH, Zhang WD. Intravoxel Incoherent Motion Diffusion-weighted Imaging: Evaluation of the Differentiation of Solid Hepatic Lesions. TranslOncol. 2017;10:831-838.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 16]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
55.  Klauss M, Mayer P, Maier-Hein K, Laun FB, Mehrabi A, Kauczor HU, Stieltjes B. IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners. Eur J Radiol. 2016;85:1289-1294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 44]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
56.  Yoon JH, Lee JM, Yu MH, Kiefer B, Han JK, Choi BI. Evaluation of hepatic focal lesions using diffusion-weighted MR imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters. J MagnReson Imaging. 2014;39:276-285.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 79]  [Cited by in F6Publishing: 88]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
57.  Watanabe H, Kanematsu M, Goshima S, Kajita K, Kawada H, Noda Y, Tatahashi Y, Kawai N, Kondo H, Moriyama N. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T. ActaRadiol. 2014;55:1166-1173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 32]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
58.  Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T. Intravoxel incoherent motion imaging of focal hepatic lesions. J MagnReson Imaging. 2013;37:1371-1376.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 45]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
59.  Doblas S, Wagner M, Leitao HS, Daire JL, Sinkus R, Vilgrain V, Van Beers BE. Determination of malignancy and characterization of hepatic tumor type with diffusion-weighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements. Invest Radiol. 2013;48:722-728.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 51]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
60.  Penner AH, Sprinkart AM, Kukuk GM, Gütgemann I, Gieseke J, Schild HH, Willinek WA, Mürtz P. Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. EurRadiol. 2013;23:2773-2783.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 47]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
61.  Zhu L, Cheng Q, Luo W, Bao L, Guo G. A comparative study of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters for the characterization of common solid hepatic tumors. ActaRadiol. 2015;56:1411-1418.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 30]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
62.  Shinmoto H, Tamura C, Soga S, Shiomi E, Yoshihara N, Kaji T, Mulkern RV. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. AJR Am J Roentgenol. 2012;199:W496-W500.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 90]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
63.  Wei Y, Gao F, Zheng D, Huang Z, Wang M, Hu F, Chen C, Duan T, Chen J, Cao L, Song B. Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging. Oncotarget. 2018;9:7975-7983.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 16]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
64.  Shao S, Shan Q, Zheng N, Wang B, Wang J. Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018. Cancer BiotherRadiopharm. 2019;34:511-518.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
65.  Choi IY, Lee SS, Sung YS, Cheong H, Lee H, Byun JH, Kim SY, Lee SJ, Shin YM, Lee MG. Intravoxel incoherent motion diffusion-weighted imaging for characterizing focal hepatic lesions: Correlation with lesion enhancement. J MagnReson Imaging. 2017;45:1589-1598.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 24]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
66.  Peng J, Zheng J, Yang C, Wang R, Zhou Y, Tao YY, Gong XQ, Wang WC, Zhang XM, Yang L. Intravoxel incoherent motion diffusion-weighted imaging to differentiate hepatocellular carcinoma from intrahepatic cholangiocarcinoma. Sci Rep. 2020;10:7717.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 14]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
67.  Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology. 2014;270:758-767.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 145]  [Cited by in F6Publishing: 162]  [Article Influence: 14.7]  [Reference Citation Analysis (0)]
68.  Zhu SC, Liu YH, Wei Y, Li LL, Dou SW, Sun TY, Shi DP. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World J Gastroenterol. 2018;24:929-940.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 31]  [Cited by in F6Publishing: 30]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
69.  Wei Y, Gao F, Wang M, Huang Z, Tang H, Li J, Wang Y, Zhang T, Wei X, Zheng D, Song B. Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest. EurRadiol. 2019;29:535-544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 33]  [Article Influence: 6.6]  [Reference Citation Analysis (0)]
70.  Yang D, She H, Wang X, Yang Z, Wang Z. Diagnostic accuracy of quantitative diffusion parameters in the pathological grading of hepatocellular carcinoma: A meta-analysis. J MagnReson Imaging. 2020;51:1581-1593.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 14]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
71.  Sokmen BK, Sabet S, Oz A, Server S, Namal E, Dayangac M, Dogusoy GB, Tokat Y, Inan N. Value of Intravoxel Incoherent Motion for Hepatocellular Carcinoma Grading. Transplant Proc. 2019;51:1861-1866.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 16]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
72.  Ichikawa S, Motosugi U, Hernando D, Morisaka H, Enomoto N, Matsuda M, Onishi H. Histological Grading of Hepatocellular Carcinomas with Intravoxel Incoherent Motion Diffusion-weighted Imaging: Inconsistent Results Depending on the Fitting Method. MagnReson Med Sci. 2018;17:168-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
73.  Li M, Zheng XJ, Huang ZX, Song B. [Predicting Histological Grade of HCC in Rats using Intravoxel Incoherent Motion Imaging]. Sichuan Da XueXueBao Yi Xue Ban. 2018;49:243-247.  [PubMed]  [DOI]  [Cited in This Article: ]
74.  Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R, Izzo F, Petrillo A. The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer. 2018;13:23.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 46]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
75.  Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F, Avallone A, Piccirillo M, Palaia R, Izzo F, Petrillo A. Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade. Oncotarget. 2016;7:79357-79364.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 61]  [Article Influence: 10.2]  [Reference Citation Analysis (0)]
76.  Zhang Y, Kuang S, Shan Q, Rong D, Zhang Z, Yang H, Wu J, Chen J, He B, Deng Y, Roberts N, Shen J, Venkatesh SK, Wang J. Can IVIM help predict HCC recurrence after hepatectomy? EurRadiol. 2019;29:5791-5803.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 15]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
77.  Wei Y, Huang Z, Tang H, Deng L, Yuan Y, Li J, Wu D, Wei X, Song B. IVIM improves preoperative assessment of microvascular invasion in HCC. EurRadiol. 2019;29:5403-5414.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 50]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
78.  Zhao W, Liu W, Liu H, Yi X, Hou J, Pei Y, Liu H, Feng D, Liu L, Li W. Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging. PLoS One. 2018;13:e0197488.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 30]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
79.  Li H, Zhang J, Zheng Z, Guo Y, Chen M, Xie C, Zhang Z, Mei Y, Feng Y, Xu Y. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma. Eur J Radiol. 2018;105:65-71.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 41]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
80.  Wagner M, Doblas S, Daire JL, Paradis V, Haddad N, Leitão H, Garteiser P, Vilgrain V, Sinkus R, Van Beers BE. Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology. 2012;264:464-472.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 59]  [Cited by in F6Publishing: 67]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
81.  Chiaradia M, Baranes L, Van Nhieu JT, Vignaud A, Laurent A, Decaens T, Charles-Nelson A, Brugières P, Katsahian S, Djabbari M, Deux JF, Sobhani I, Karoui M, Rahmouni A, Luciani A. Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis? J MagnReson Imaging. 2014;39:317-325.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 55]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
82.  Yang L, Zhang XM, Tan BX, Liu M, Dong GL, Zhai ZH. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma. J Comput Assist Tomogr. 2012;36:226-230.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 27]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
83.  Yang L, Zhang XM, Zhou XP, Tang W, Guan YS, Zhai ZH, Dong GL. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization. J VascIntervRadiol. 2010;21:1841-1846.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 25]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
84.  Yang K, Zhang XM, Yang L, Xu H, Peng J. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2016;22:4835-4847.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 20]  [Cited by in F6Publishing: 20]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
85.  Pieper CC, Sprinkart AM, Meyer C, König R, Schild HH, Kukuk GM, Mürtz P. Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single Center Analysis. Medicine (Baltimore). 2016;95:e3275.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
86.  Wu L, Xu P, Rao S, Yang L, Chen C, Liu H, Fu C, Zeng M. ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J MagnReson Imaging. 2017;46:820-830.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 21]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
87.  Shirota N, Saito K, Sugimoto K, Takara K, Moriyasu F, Tokuuye K. Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study. Cancer Imaging. 2016;16:1.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 42]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
88.  Lee Y, Lee SS, Cheong H, Lee CK, Kim N, Son WC, Hong SM. Intravoxel incoherent motion MRI for monitoring the therapeutic response of hepatocellular carcinoma to sorafenib treatment in mouse xenograft tumor models. ActaRadiol. 2017;58:1045-1053.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
89.  Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS, Kim KA, Park CM. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. MagnReson Imaging. 2014;32:638-646.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 40]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
90.  Lin M, Tian MM, Zhang WP, Xu L, Jin P. Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma. Onco Targets Ther. 2016;9:7029-7037.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 12]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
91.  Peng J, Yang C, Zheng J, Wang R, Zhou Y, Wang W, Yang L, Zhang X, Miao N, Ren Y, Xu H, Min X. Intravoxel Incoherent Motion Diffusion Weighted Imaging for the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma. Journal of Cancer Therapy. 2019;591-60110.4236/jct.2019.107048].  [PubMed]  [DOI]  [Cited in This Article: ]
92.  Wu LF, Rao SX, Xu PJ, Yang L, Chen CZ, Liu H, Huang JF, Fu CX, Halim A, Zeng MS. Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma. EurRadiol. 2019;29:213-223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 21]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
93.  Server S, Sabet S, Bilgin R, Inan N, Yuzer Y, Tokat Y. Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation. Transplant Proc. 2019;51:2391-2396.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
94.  Lewin M, Fartoux L, Vignaud A, Arrivé L, Menu Y, Rosmorduc O. The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. EurRadiol. 2011;21:281-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 119]  [Article Influence: 8.5]  [Reference Citation Analysis (0)]
95.  Yang SH, Lin J, Lu F, Han ZH, Fu CX, Lv P, Liu H, Gao DM. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model. J MagnReson Imaging. 2017;45:270-280.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 27]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
96.  Joo I, Lee JM, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors. Radiology. 2014;272:417-426.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 71]  [Article Influence: 7.1]  [Reference Citation Analysis (0)]
97.  Ye W, Li J, Guo C, Chen S, Liu YB, Liu Z, Wu H, Wang G, Liang C. Can intravoxel incoherent motion diffusion-weighted imaging characterize the cellular injury and microcirculation alteration in hepatic ischemia-reperfusion injury? An animal study. J MagnReson Imaging. 2016;43:1327-1336.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
98.  Ji Q, Chu ZQ, Ren T, Xu SC, Zhang LJ, Shen W, Lu GM. Multiparametric functional magnetic resonance imaging for evaluation of hepatic warm ischemia-reperfusion injury in a rabbit model. BMC Gastroenterol. 2017;17:161.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
99.  Moon CM, Shin SS, Lim NY, Kim SK, Kang YJ, Kim HO, Lee SJ, Beak BH, Kim YH, Jeong GW. Metabolic alterations in a rat model of hepatic ischaemia reperfusion injury: In vivo hyperpolarized 13 C MRS and metabolic imaging. Liver Int. 2018;38:1117-1127.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
100.  Abudureheman Y, Wang J, Liu W. Comparison of Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance (MR) Imaging to T1 Mapping in Characterization of Hepatic Alveolar Echinococcosis. Med SciMonit. 2017;23:6019-6025.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 7]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
101.  Ding L, Xiao L, Lin X, Xiong C, Lin L, Chen S. Intravoxel Incoherent Motion (IVIM) Diffusion-Weighted Imaging (DWI) in Patients with Liver Dysfunction of Chronic Viral Hepatitis: Segmental Heterogeneity and Relationship with Child-Turcotte-Pugh Class at 3 Tesla. Gastroenterol Res Pract. 2018;2018:2983725.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
102.  Hong EK, Joo I, Park J, Lee K. Assessment of hepatic sinusoidal obstruction syndrome with intravoxel incoherent motion diffusion-weighted imaging: An experimental study in a rat model. J MagnReson Imaging. 2020;51:81-89.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 7]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]